ID   PC-3 cFER S-A2
AC   CVCL_F0RZ
SY   S-A2
RX   PubMed=10687853;
CC   Population: Caucasian.
CC   Doubling time: 31 +- 2 hours (PubMed=10687853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:40818; Dog FER (Note=420 bp fragment of coding region in sense orientation).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=10687853; DOI=10.1016/s0303-7207(99)00205-1;
RA   Allard, Pierre
RA   Zoubeidi, Amina
RA   Nguyen, Linh T.
RA   Tessier, Sylvain
RA   Tanguay, Simon
RA   Chevrette, Mario
RA   Aprikian, Armen Garo
RA   Chevalier, Simone
RT   "Links between Fer tyrosine kinase expression levels and prostate cell
RT   proliferation.";
RL   Mol. Cell. Endocrinol. 159:63-77(2000).
//